Neogen Chemicals Ltd is Rated Hold

1 hour ago
share
Share Via
Neogen Chemicals Ltd is rated 'Hold' by MarketsMojo, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 13 August 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.
Neogen Chemicals Ltd is Rated Hold

Current Rating and Its Significance

MarketsMOJO’s 'Hold' rating for Neogen Chemicals Ltd indicates a neutral stance on the stock, suggesting that investors should neither aggressively buy nor sell at this juncture. This rating reflects a balance between the company’s strengths and challenges, signalling that while the stock has potential, it also carries risks that warrant caution. The 'Hold' grade is supported by a Mojo Score of 64.0, a notable improvement from the previous 'Sell' rating with a score of 42, reflecting a positive shift in the company’s outlook as of the rating update date.

Quality Assessment

As of 13 August 2026, Neogen Chemicals exhibits an average quality grade. The company’s ability to generate returns on equity remains modest, with an average ROE of 6.86%, indicating limited profitability relative to shareholders’ funds. Additionally, the firm faces challenges in servicing its debt, with a high Debt to EBITDA ratio of 10.16 times, which raises concerns about financial leverage and long-term sustainability. Operating profit growth over the past five years has been moderate, at an annualised rate of 15.92%, reflecting steady but unspectacular expansion.

Valuation Considerations

The valuation grade for Neogen Chemicals is classified as very expensive. The company’s Return on Capital Employed (ROCE) stands at a low 5%, yet it trades at an Enterprise Value to Capital Employed ratio of 3.2, suggesting that the market prices the stock at a premium relative to the capital it employs. Despite this, the stock currently trades at a discount compared to its peers’ average historical valuations, which may offer some relative value to discerning investors. This valuation dynamic underscores the importance of cautious appraisal before committing capital.

Financial Trend and Recent Performance

The financial trend for Neogen Chemicals is positive, with recent quarterly results showing signs of recovery. After four consecutive quarters of negative performance, the company reported a strong quarter in June 2026. Net sales reached a record high of ₹250.29 crores, while Profit Before Depreciation, Interest and Taxes (PBDIT) hit ₹48.23 crores. Profit After Tax (PAT) for the quarter surged by 138.4% compared to the average of the previous four quarters, standing at ₹17.11 crores. However, over the past year, despite the stock delivering a robust return of 49.89%, the company’s profits have declined by 17%, highlighting some volatility in earnings.

Technical Outlook

From a technical perspective, Neogen Chemicals is currently rated bullish. The stock has demonstrated strong momentum, with a 6-month return of 63.32% and a year-to-date gain of 77.57%. The one-day change as of 13 August 2026 was +1.47%, reflecting positive investor sentiment. This technical strength suggests that the stock may continue to attract interest in the near term, although investors should weigh this against the fundamental challenges outlined.

Summary for Investors

In summary, Neogen Chemicals Ltd’s 'Hold' rating reflects a nuanced view of the company’s current position. Investors should recognise the stock’s recent operational improvements and strong price momentum, balanced against concerns over high debt levels, expensive valuation, and modest profitability. The rating advises a measured approach, where existing shareholders may consider holding their positions while new investors might await clearer signs of sustained financial improvement before entering.

Quarter after quarter, this Small Cap from the Lifestyle sector delivers without fail! Just added to our Reliable Performers with proven staying power. Stability meets growth here beautifully.

  • - Consistent quarterly delivery
  • - Proven staying power
  • - Stability with growth

See the Consistent Performer →

Contextualising the Rating Change

The transition from a 'Sell' to a 'Hold' rating on 25 May 2026 was driven by improvements in the company’s operational performance and technical indicators. The Mojo Score’s increase by 22 points to 64 reflects these positive developments. However, the rating does not imply a strong buy signal but rather a cautious optimism, recognising that while the company is stabilising, it still faces significant challenges, particularly in debt management and valuation.

Industry and Market Position

Operating within the specialty chemicals sector, Neogen Chemicals is classified as a small-cap company. This sector is often subject to cyclical demand and raw material price volatility, which can impact earnings consistency. The company’s recent quarterly turnaround is encouraging, but investors should remain mindful of sector-specific risks and the company’s relatively high leverage.

Investor Takeaway

For investors, the 'Hold' rating suggests maintaining a balanced portfolio approach with Neogen Chemicals. Those already invested may consider holding their shares to benefit from potential further recovery, while new investors might prefer to monitor upcoming quarters for sustained profitability and debt reduction before increasing exposure. The stock’s technical strength offers some upside potential, but valuation and financial risks temper enthusiasm.

Looking Ahead

Going forward, key factors to watch include the company’s ability to reduce its debt burden, improve profitability metrics such as ROE and ROCE, and sustain sales growth. Continued positive quarterly results will be critical to justifying a more favourable rating. Investors should also keep an eye on broader market conditions and sector trends that could influence the stock’s performance.

Conclusion

Neogen Chemicals Ltd’s current 'Hold' rating by MarketsMOJO reflects a stock at a crossroads. While recent operational improvements and bullish technicals provide reasons for cautious optimism, the company’s expensive valuation and financial leverage warrant prudence. This rating advises investors to carefully weigh the risks and rewards, maintaining a watchful stance as the company navigates its growth trajectory.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News